Share on LinkedInShare on LinkedIn

ARTICLE · 08 DECEMBER 2021

Prior Art Reporting Failure Does Not Provide Expectation Of Success

The patent at issue was the University of Strathclyde's U.S. Patent No. 9,839,706, directed to methods for inactivating Gram-positive bacteria such as MRSA.

United StatesIntellectual Property

The patent at issue was the University of Strathclyde's U.S. Patent No. 9,839,706, directed to methods for inactivating Gram-positive bacteria such as MRSA.

Claim 1 of the '706 patent recites, in relevant part:

1. A method for disinfecting air, contact surfaces or materials by inactivating one or more pathogenic Gram-positive bacteria in the air, on the contact surfaces or on the materials, said method comprising exposing the one or more pathogenic Gram-positive bacteria to visible light without using a photosensitizer ...

The highlighted phrase was a feature at issue.

The IPR Decision

Clear-Vu challenged the patent in an Inter Partes Review (IPR) proceeding. The PTAB found claims 1-4 obvious over two prior art references: Ashkenazi, which reported an experiment to photoinactivate Gram-positive bacteria using photosensitizers, and Nitzan, which reported an experiment showing photoinactivation of MRSA only when photosensitizers were used. The PTAB

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from